BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Significant Increase in Short Interest

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 12,800 shares, a growth of 341.4% from the November 15th total of 2,900 shares. Based on an average daily volume of 146,600 shares, the days-to-cover ratio is presently 0.1 days.

BriaCell Therapeutics Price Performance

Shares of BriaCell Therapeutics stock traded down $0.16 during trading hours on Friday, reaching $0.38. 209,443 shares of the company’s stock were exchanged, compared to its average volume of 86,642. The business has a fifty day moving average of $0.34 and a two-hundred day moving average of $0.30. BriaCell Therapeutics has a 1 year low of $0.11 and a 1 year high of $2.60.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.